InsidersTradesSigma
Browse the detailed record of transactions filed by Martin Jönsson, 董事长兼首席执行官. Director active across 4 companies, notably AlzeCure Pharma AB. Aggregated, 3 filings have been published. Activity tracked since 25 August 2025. The latest transaction was disclosed on 6 March 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Martin Jönsson is the CEO of AlzeCure Pharma AB. He leads the company in developing new therapies for neurodegenerative diseases. With a strong background in the pharmaceutical sector, he is committed to advancing research projects and strengthening AlzeCure's market position. Under his leadership, the company has focused on innovation and collaboration with other industry players.